Quarterly report [Sections 13 or 15(d)]

Revenues - Schedule of Revenues Disaggregated by Category (Details)

v3.26.1
Revenues - Schedule of Revenues Disaggregated by Category (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Disaggregation of Revenue [Line Items]    
Total revenues $ 58,818 $ 53,333
Product sales, net    
Disaggregation of Revenue [Line Items]    
Total revenues 54,923 43,550
Gross product sales    
Disaggregation of Revenue [Line Items]    
Total revenues 75,388 60,192
Discounts and allowances    
Disaggregation of Revenue [Line Items]    
Total revenues (20,465) (16,642)
Contract revenues from collaborations    
Disaggregation of Revenue [Line Items]    
Total revenues 3,895 9,783
Development Milestones    
Disaggregation of Revenue [Line Items]    
Total revenues 0 3,000
Delivery of drug supplies, royalties and others    
Disaggregation of Revenue [Line Items]    
Total revenues $ 3,895 $ 6,783